This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
COVID
+1

Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19

Sponsored by Region MidtJylland Denmark

About this trial

Last updated 4 years ago

Study ID

FHM-1-2020

Status

Unknown status

Type

Observational [Patient Registry]

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Trial Timing

Ended 4 years ago

What is this trial about?

Determination of IgM and IgG antibodies against SARS-CoV-2 in dialysis patients by continous monitoring in the period from March 2020 to december 2020

What are the participation requirements?

Yes

Inclusion Criteria

- Dialysis

No

Exclusion Criteria

- Not willing to give consent

Locations

Location

Status

Recruiting